(14 days)
Not Found
No
The device description focuses on the mechanical components and procedure for interstitial brachytherapy. There is no mention of AI or ML in the intended use, device description, or sections specifically looking for AI/ML mentions, training/test sets, or performance metrics typically associated with AI/ML.
Yes
The device is used in Brachytherapy procedures, which involve delivering radiation to treat diseases, thus making it a therapeutic device.
No
This device is an accessory for brachytherapy procedures, providing a path for a radioactive source to deliver treatment. While imaging is used to determine the applicator's location for treatment planning, the device itself is not designed to diagnose a condition.
No
The device description clearly outlines multiple physical components, including needles, tubes, buttons, templates, and tools for cutting and molding. It is a hardware system used in a medical procedure.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood or tissue, to detect diseases, conditions, or infections.
- Device Function: The Comfort Catheter System is a medical device used in vivo (within the body) for delivering radiation therapy (brachytherapy). It provides a path for a radioactive source to treat a tumor.
- Intended Use: The intended use clearly states it's for "interstitial Brachytherapy procedures."
- Device Description: The description details the physical components and how they are inserted into the body to facilitate radiation delivery.
- Lack of Diagnostic Function: The device itself does not perform any diagnostic tests on biological samples. While imaging is used to plan the treatment, the device's function is therapeutic, not diagnostic.
Therefore, the Comfort Catheter System is a therapeutic medical device, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
Comfort Catheter System is intended for interstitial Brachytherapy procedures involving the Nucletron remote afterloading equipment: mHDR.
Product codes (comma separated list FDA assigned to the subject device)
90 JAQ
Device Description
The Nucletron Comfort Catheter System as described in this submission is designed as an accessory to the Nucletron remote afterloading equipment. mHDR and is intended for interstitial Brachytherapy procedures.
The device consists of a Leader insertion needle with an opturator which is inserted through the skin surface into the target volume. I.e. breast. The opturator is ther removed and the flexible implant tube is inserted into hollow needle, the hollow needle is retracted when the flexible implant tube is in place. Optional a template can be used for positioning the insertion needles.
Once the catheter is in place the insertion needle is removed and a button is placed over the plastic catheter and slid into contact with the skin surface. .The Flexible implant tube is pulled in position until the distal button is in contact with the skin surface. The proximal button is pulled over the flexible implant tube, until the button is in contact with the skin surface. The flexible implant tubes are cut off. at a predetermined length with the cutter. A flange is molded on the flexible implant tube with the flange molding tool, to fixate the proximal button.
X-ray catheters or CT markers are inserted into the Proguide treatment needles for visualisation. Radiographic images, planar films or transverse slices, i.e. CT, MR is obtained to determine the precise location of the applicator within the body. This information is then used for Brachytherapy treatment planning purposes.
The Proguide treatment needles are a closed system to prevent the radioactive source from coming in contact with body fluids. The treatment catheter does not control the treatment unit; it strictly provides a treatment path for the radioactive source. The afterloader and the clinical staff verify that the applicator is properly attached prior to treatment.
For the first treatment a closed end Proguide treatment needle is inserted up to the distal end of the flexible implant tube. The Proguide treatment needle is immobilised with a stoptag. The Proquide treatment needle is attached to the afterloader (treatment head), using transfer tubes. When the applicator is attached, a check cable run is performed to ensure that the applicator is properly attached and that there are no obstructions, which will interrupt treatment, After the check cable run, the radioactive source will step through the applicator to deliver the prescribed dose of radiation.
After the treatment the Proguide treatment needles are disconnected from the attached transfer tubes and from the implant (flexible implant tubes) by using the stop tags. In between treatment fractions the Proquide treatment needle are stored in a patient treatment box. The Stop tags must remain fixed on the Proguide treatment needles for the next fraction. When the course of treatment is completed the flexible implant tubes and buttons are removed from the patient.
The device uses similar (implantable) materials as the legally marketed predicate device cited (Implant Guidance System). With respect to the legally marketed predicate device cited (MicroSelectron HDR V2: Breast Template), the implant technique has been optimised for interstitial techniques such as breast implants, no longer the catheters are protruding from the patients body in between fractions. This increases the patient comfort and flexibility. It is also easier for the hospital staff to apply and remove the catheters.
The Comfort Catheter System is used as an accessory to the Nucletron microSelectron.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Radiographic images, planar films or transverse slices, i.e. CT, MR
Anatomical Site
Breast
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Clinical staff / Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.5700 Remote controlled radionuclide applicator system.
(a)
Identification. A remote controlled radionuclide applicator system is an electromechanical or pneumatic device intended to enable an operator to apply, by remote control, a radionuclide source into the body or to the surface of the body for radiation therapy. This generic type of device may include patient and equipment supports, component parts, treatment planning computer programs, and accessories.(b)
Classification. Class II.
0
AUG 15 2003
K∅32372
Image /page/0/Picture/2 description: The image shows the word "Nucletron" in a bold, sans-serif font. To the left of the word is a square graphic. Inside the square is a black shape with two white circles on either side.
NUCLETRON B.V.
Waardgelder 1 3905 TH Veenendaal P.O.Box 930 3900 AX Veenendaal The Netherlands Phone +31 318 557133 +31 318 550485 Fax
Department of Health and Human Services Centre of Device and Radiological Health Office of Device Evaluation Special 510(k) section
510(K) SUMMARY OF SAFETY AND EFFECTIVENESS INFORMATION
as required by section 807.92(c)
Submitter of 510(k):
. ● .. .
| Company name: | Nucletron Corporation |
|---|---|
| Registration number: | 1121753 |
| Address: | 7080 Columbia Gateway Drive |
| Columbia, MD 21046-2133 | |
| Phone: | 410-312-4100 |
| Fax: | 410-312-4197 |
| Correspondent : | Lisa Dimmick |
| Director Assurance & Regulatory Affairs |
Modified Device Name:
| Trade/Proprietary Name: | Comfort Catheter System |
|---|---|
| Common/Usual Name: | Remote Afterloading for interstitial Brachytherapy applications |
| Classification Name: | Remote controlled radionucide applicator system accessory |
| Classification: | 21Cfr892.5700 Class II |
Legally Marketed Device(s)
Our device is substantially equivalent to the legally marketed predicate device cited in the table below:
| ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Manufacturer
with the first and states and the different of the different to the distribution of the distribution of the distribution of the distribution of the discussion of the discussi | Device | 510(k) #
Party Comment of the free and reserved reality of the first of the first and the first and the first and the first and the first and the first and the first and the first and |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Nucletron BV | I Implant Guidance System | K020015 |
Description:
The Nucletron Comfort Catheter System as described in this submission is designed as an accessory to the Nucletron remote afterloading equipment. mHDR and is intended for interstitial Brachytherapy procedures.
The device consists of a Leader insertion needle with an opturator which is inserted through the skin surface into the target volume. I.e. breast. The opturator is ther removed and the
1
K 43237Z
flexible implant tube is inserted into hollow needle, the hollow needle is retracted when the flexible implant tube is in place. Optional a template can be used for positioning the insertion needles.
Once the catheter is in place the insertion needle is removed and a button is placed over the plastic catheter and slid into contact with the skin surface. .The Flexible implant tube is pulled in position until the distal button is in contact with the skin surface. The proximal button is pulled over the flexible implant tube, until the button is in contact with the skin surface. The flexible implant tubes are cut off. at a predetermined length with the cutter. A flange is molded on the flexible implant tube with the flange molding tool, to fixate the proximal button.
X-ray catheters or CT markers are inserted into the Proguide treatment needles for visualisation. Radiographic images, planar films or transverse slices, i.e. CT, MR is obtained to determine the precise location of the applicator within the body. This information is then used for Brachytherapy treatment planning purposes.
The Proguide treatment needles are a closed system to prevent the radioactive source from coming in contact with body fluids. The treatment catheter does not control the treatment unit; it strictly provides a treatment path for the radioactive source. The afterloader and the clinical staff verify that the applicator is properly attached prior to treatment.
For the first treatment a closed end Proguide treatment needle is inserted up to the distal end of the flexible implant tube. The Proguide treatment needle is immobilised with a stoptag. The Proquide treatment needle is attached to the afterloader (treatment head), using transfer tubes. When the applicator is attached, a check cable run is performed to ensure that the applicator is properly attached and that there are no obstructions, which will interrupt treatment, After the check cable run, the radioactive source will step through the applicator to deliver the prescribed dose of radiation.
After the treatment the Proguide treatment needles are disconnected from the attached transfer tubes and from the implant (flexible implant tubes) by using the stop tags. In between treatment fractions the Proquide treatment needle are stored in a patient treatment box. The Stop tags must remain fixed on the Proguide treatment needles for the next fraction. When the course of treatment is completed the flexible implant tubes and buttons are removed from the patient.
The device uses similar (implantable) materials as the legally marketed predicate device cited (Implant Guidance System). With respect to the legally marketed predicate device cited (MicroSelectron HDR V2: Breast Template), the implant technique has been optimised for interstitial techniques such as breast implants, no longer the catheters are protruding from the patients body in between fractions. This increases the patient comfort and flexibility. It is also easier for the hospital staff to apply and remove the catheters.
The Comfort Catheter System is used as an accessory to the Nucletron microSelectron.
Intended use:
The modified device has the same intended use as the legally marketed predicate device cited:
Comfort Catheter System is intended for interstitial Brachytherapy procedures involving the Nucletron remote afterloading equipment: mHDR.
Summary of tecnnological considerations:
2
The Comfort Catheter System is substantially equivalent to the cleared predicate device, Comfort Catheter System, 510(k)#: K020015.
ts van Krieken
Name: Frits van Krieken Title: Business Segment Manager Nucletron B.V. Veenendaal, The Netherlands
13-06-2003
Date
3
Image /page/3/Picture/1 description: The image shows a black and white logo for the Department of Health & Human Services - USA. The logo is circular, with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter of the circle. Inside the circle is an abstract symbol that resembles a stylized bird or a wing-like shape, composed of three curved lines.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
AUG 15 2003
Re: K032372
Trade/Device Name: Comfort Catheter System Regulation Number: 21 CFR 892.5700 Regulation Name: Remote controlled radionuclide applicator system Regulatory Class: II Product Code: 90 JAQ Dated: July 31, 2003 Received: August 1, 2003
Dear Mr. Ruys:
Nucletron B.V.
% Mr. Peter N. Ruys
KEMA Quality B.V.
NL-6812 AR Arnhem
THE NETHERLANDS
Utrechtseweg 310
Responsible Third Party Official
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.
4
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of the letter:
| 8xx.1xxx | (301) 594-4591 |
|---|---|
| 876.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4616 |
| 884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx | (301) 594-4616 |
| 892.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4654 |
| Other | (301) 594-4692 |
Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97) you may obtain. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.
Sincerely yours,
Nancy C. Brogdon
Nancy C. Brogdon Director, Division of Reproductive, Abdominal and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Indications for Use Statement
510(k) Number
K$\phi$32372
Device Name
Comfort Catheter System
Indications for Use
Comfort Catheter System is intended for interstitial Brachytherapy procedures involving the Nucletron remote afterloading equipment: mHDR.
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use
(Per 21 CFR 801.109)
OR
Over-The-Counter Use__________________________________________________________________________________________________________________________________________________________
David A. Lyman
(Division Sign-Off) Division of Reproductive, Abdo and Radiological Devic 510(k) Numb